WCM
PFE icon

Westend Capital Management’s Pfizer PFE Stock Holding History

Westend Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.79K Hold
199
– – ﹤0.01% 180
2026
Q1 		$5.59K Buy
+199
New +$5.3K ﹤0.01% 187
2025
Q1 		– Sell
-1,767
Closed -$46.9K – 253
2024
Q4 		$46.9K Hold
1,767
– – 0.01% 77
2024
Q3 		$51.1K Hold
1,767
– – 0.02% 74
2024
Q2 		$49.9K Buy
+1,767
New +$48.6K 0.02% 65
2016
Q3 		$263K Buy
+8,174
New +$273K 0.37% 55
2016
Q2 		– Sell
-8,342
Closed -$235K – 74
2016
Q1 		$235K Buy
+8,342
New +$238K 0.32% 57

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Westend Capital Management's PFE Position: Q2 2026 in Review

Westend Capital Management held its Pfizer (PFE) position steady in Q2 2026 at 199 shares worth $4.79K. The position accounts for ﹤0.01% of the portfolio, ranked #180.

Westend Capital Management first reported a position in PFE in Q1 2016 and has held it in 7 quarters since. The position peaked at $263K in Q3 2016. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Westend Capital Management held 199 shares of Pfizer worth $4.79K as of Q2 2026.
  • Westend Capital Management left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up ﹤0.01% of Westend Capital Management's portfolio in Q2 2026, its #180 holding.
  • Westend Capital Management first reported a position in Pfizer in Q1 2016 and has held it in 7 quarters since.
  • Westend Capital Management's Pfizer position peaked at $263K in Q3 2016.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Westend Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.